Leading French Research Organization Benefits from Fragment Analyzer Usage
Published: Tuesday, August 27th, 2013
Tags: Customer Stories, Fragment Analyzer
The Institut Pasteur’s Genopole in Paris has three technological platforms, including the Genomic Platform. The activities of the Genomic Platform are mainly dedicated to the whole genome sequencing application for microbial genomes. Using the HiSeq® 2000 system and the MiSeq® system from Illumina as a next-generation sequencing (NGS) technology, the Genomic Platform carries out resequencing and de novo sequencing projects for the microbial scientific community.
Since February 2013, the Fragment Analyzer Automated CE System has been installed within the Institut Pasteur’s Genomic Platform to perform quality control steps during the process of NGS library preparation, according to Dr. Christiane Bouchier, Head of the Genomic Platform at Institut Pasteur. The Fragment Analyzer is used to quantify and qualify NGS fragments.
“This instrument has allowed for acceleration of the lab's workflow by increasing sample throughput,” said Dr. Bouchier. “Easy to use and versatile, it is a suitable instrument for the analysis of both small and large samples. Moreover, the Fragment Analyzer is an instrument which can be easily shared by several laboratories at the research facility.”
“A world-class organization such as Institut Pasteur routinely using our technology – now that’s very exciting news!” said Dr. Steven J. Lasky, CEO of Advanced Analytical Technologies, Inc., which makes the Fragment Analyzer™. “From our laboratory in Heidelberg, Germany, we have installed more than 90 instruments throughout Europe. The Institut Pasteur is one of our most prestigious clients.”
“Scientists around the world recognize the name ‘Pasteur’ because of the history associated with it,” Lasky said. “And Institut Pasteur continues to break new ground. Recently, they discovered several genetic factors that control the transmission of various dengue strains in mosquitoes. That discovery will help scientists to combat dengue disease. This is what makes us so proud: that our technology can play a role in assisting scientists to make advancements that will improve the human experience.”
About Genopole, Institut Pasteur, Paris
Institut Pasteur's Genopole gathers high technology equipment and scientific skills for the achievement of projects in the fields of genetics, population genomics, molecular epidemiology, transcriptomics, epigenomics and bio-informatics. Institut Pasteur’s researchers use it to address fundamental questions in microbiology and in the study of genetic and epigenetic programming during embryo development, in the generation and development of cancers, and during stem cell differentiation. At Genopole, 34 researchers, engineers, and technicians with a wide variety of skills are involved in fundamental research and public health projects. All the Genopole platforms have received official accreditation from the GIS IBiSA (Scientific Interest Group–Infrastructure for Biology, Health and Agronomy) and are partners of France Génomique, the nationalinfrastructure for biology and health.
About Advanced Analytical
With headquarters in Ames, Iowa, Advanced Analytical Technologies, Inc. (AATI) provides innovative solutions to improve processes and accelerate research within the pharmaceutical, life science, and biotechnology markets. AATI's portfolio includes technologies for the parallel analysis of biomolecules, nucleic acids and proteins by capillary electrophoresis. For more information visit the company’s website at https://www.aati-us.com or contact us at firstname.lastname@example.org .
Access Institut Pasteur France 2013 here.
Access Korea Research Institute of Bioscience & Biotechnology (KRIBB) 2013 here.
- AATI’s Mutation Screening Method for CRISPR Workflows Featured in GEN
- Federal Scientists Issue Report, State Need for Fragment Analyzers
- FBI’s DNA Support Unit Looks to Purchase Second Fragment Analyzer
- Interview highlights use of Fragment Analyzer in core laboratories
- Advanced Analytical Technologies, Inc. (AATI) is Part of Rewriting CRISPR Workflow